| 1 |
33361143 | Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases. | 2021 Mar 17 |
1 |
| 2 |
33499253 | Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma. | 2021 Jan 22 |
2 |
| 3 |
33942544 | Donor Treg expansion by liposomal α-galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft-versus-host disease. | 2021 Sep |
2 |
| 4 |
34524668 | The Expansion and Cytotoxicity Detection of Human iNKT Cells. | 2021 |
2 |
| 5 |
34524672 | Redirecting iNKT Cell Antitumor Immunity with α-GalCer/CD1d-scFv Fusion Proteins. | 2021 |
1 |
| 6 |
34706265 | Novel in vitro invariant natural killer T cell functional assays. | 2021 Dec |
3 |
| 7 |
34936686 | Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15. | 2021 |
1 |
| 8 |
34953481 | Invariant Natural Killer T (iNKT) cells response in human melioidosis. | 2021 Dec 26 |
1 |
| 9 |
31190065 | Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus-associated Tuberculosis. | 2020 Apr 15 |
1 |
| 10 |
31544285 | Thermodynamic and Structural Behavior of α-Galactosylceramide and C6-Functionalized α-GalCer in 2D Layers at the Air-Liquid Interface. | 2020 Jan 15 |
2 |
| 11 |
31982233 | Photo effect on the CD1d-binding ability of azobenzene-attached analogues of α-GalCer. | 2020 Mar 1 |
1 |
| 12 |
32714765 | A Designed α-GalCer Analog Promotes Considerable Th1 Cytokine Response by Activating the CD1d-iNKT Axis and CD11b-Positive Monocytes/Macrophages. | 2020 Jul |
1 |
| 13 |
33193386 | Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer. | 2020 |
2 |
| 14 |
30783507 | Synthesis of 5-Thio-α-GalCer Analogues with Fluorinated Acyl Chain on Lipid Residue and Their Biological Evaluation. | 2019 Feb 14 |
2 |
| 15 |
30858151 | Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein. | 2019 Mar 12 |
1 |
| 16 |
31141185 | Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers. | 2019 Sep |
1 |
| 17 |
31316500 | Porcine Invariant Natural Killer T Cells: Functional Profiling and Dynamics in Steady State and Viral Infections. | 2019 |
1 |
| 18 |
31615552 | Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. | 2019 Oct 15 |
1 |
| 19 |
31649670 | Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d. | 2019 |
2 |
| 20 |
31748533 | Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors. | 2019 Nov 20 |
1 |
| 21 |
29904582 | Development of a novel mechanism-based glycolipid adjuvant for vaccination. | 2018 |
2 |
| 22 |
30013569 | CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond. | 2018 |
1 |
| 23 |
30051730 | Utilization of invariant natural killer T cells for gastric cancer treatment. | 2018 Aug |
1 |
| 24 |
30245690 | Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer. | 2018 |
1 |
| 25 |
30322965 | Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. | 2018 Nov 15 |
1 |
| 26 |
30519237 | Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond. | 2018 |
1 |
| 27 |
28633979 | Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells. | 2017 Oct |
2 |
| 28 |
28655912 | Galactosylsphingamides: new α-GalCer analogues to probe the F'-pocket of CD1d. | 2017 Jun 27 |
1 |
| 29 |
29163493 | Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses. | 2017 |
1 |
| 30 |
26875526 | Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens. | 2016 Feb 15 |
2 |
| 31 |
27648599 | Isolated Polar Amino Acid Residues Modulate Lipid Binding in the Large Hydrophobic Cavity of CD1d. | 2016 Nov 18 |
2 |
| 32 |
25796193 | Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells. | 2015 May |
2 |
| 33 |
26107189 | Influence of Endosomal Escape and Degradation of α-Galactosylceramide Loaded Liposomes on CD1d Antigen Presentation. | 2015 Aug 3 |
2 |
| 34 |
26481266 | In vivo and in vitro analyses of α-galactosylceramide uptake by conventional dendritic cell subsets using its fluorescence-labeled derivative. | 2015 Dec |
1 |
| 35 |
28717498 | NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity. | 2015 Sep 1 |
1 |
| 36 |
23239102 | Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells. | 2014 Jan |
2 |
| 37 |
24498010 | An in silico approach for modelling T-helper polarizing iNKT cell agonists. | 2014 |
2 |
| 38 |
24619678 | Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines. | 2014 |
2 |
| 39 |
25452463 | The molecular bases of δ/αβ T cell-mediated antigen recognition. | 2014 Dec 15 |
2 |
| 40 |
22968995 | The bovine CD1D gene has an unusual gene structure and is expressed but cannot present α-galactosylceramide with a C26 fatty acid. | 2013 Feb |
1 |
| 41 |
23065503 | Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy. | 2013 Mar |
1 |
| 42 |
23458425 | Design, synthesis, and functional activity of labeled CD1d glycolipid agonists. | 2013 Apr 17 |
4 |
| 43 |
23518808 | The functions of type I and type II natural killer T cells in inflammatory bowel diseases. | 2013 May |
2 |
| 44 |
23615906 | Endoplasmic reticulum glycoprotein quality control regulates CD1d assembly and CD1d-mediated antigen presentation. | 2013 Jun 7 |
1 |
| 45 |
23885215 | Expression of CD1c enhances human invariant NKT cell activation by α-GalCer. | 2013 |
2 |
| 46 |
24076636 | CD1d-lipid antigen recognition by the γδ TCR. | 2013 Nov |
2 |
| 47 |
22407918 | Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression. | 2012 May 1 |
4 |
| 48 |
22445102 | Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues. | 2012 Jul 15 |
3 |
| 49 |
22639457 | Species-specific activity of glycolipid ligands for invariant NKT cells. | 2012 Jun 18 |
4 |
| 50 |
22652050 | New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides. | 2012 Jul 1 |
1 |